About

Frank Piscotta is a Research Scientist in the in vitro biology section of the Drug Discovery group at the Lieber Institute. After acquiring his B.E. in Chemical Engineering from The Cooper Union, he obtained his Ph.D. from Princeton University in 2018, where he worked in the laboratory of Dr. A. James Link. His thesis work investigated the unique lasso peptide class of natural products, as well as their related biosynthetic gene clusters. He then performed his postdoctoral research in the laboratory of Dr. Sean Brady at Rockefeller University, where he continued his work with natural products, this time pertaining to their roles within the human microbiome. In 2021, Frank arrived at the Lieber Institute, where he leads the development of high-content imaging assays and computational pipelines and builds the foundations of a cellular phenomics approach to drug screening in schizophrenia.